AROP Association pour le Rayonnement de l’Opéra na – Trademark Portfolio

Entity Type: 99

AROP Association pour le Rayonnement de l’Opéra na holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 35 (Advertising & Business) — 1 filings in this category. The portfolio also extends into Class 41 (Education & Entertainment) across 3 Nice Classification classes.

Palais Garnier,

8 rue Scribe F-75009 Paris

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

AROP Association pour le Rayonnement de l’Opéra na's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

35
Advertising & Business (1 filing)

Advertising; business management; business administration; office functions

41
Education & Entertainment (1 filing)

Education; providing of training; entertainment; sporting and cultural activities

36
Insurance & Financial (1 filing)

Insurance; financial affairs; monetary affairs; real estate affairs

Frequently Asked Questions

How many trademarks does AROP Association pour le Rayonnement de l’Opéra na have?

AROP Association pour le Rayonnement de l’Opéra na has 1 U.S. trademark filed with the USPTO.

What trademark classes does AROP Association pour le Rayonnement de l’Opéra na file in?

AROP Association pour le Rayonnement de l’Opéra na files trademarks across 3 Nice Classification classes. The most active classes are Class 35 (Advertising & Business), Class 41 (Education & Entertainment), Class 36 (Insurance & Financial). Class 35 covers advertising; business management; business administration; office functions.

What is AROP Association pour le Rayonnement de l’Opéra na's trademark registration success rate?

AROP Association pour le Rayonnement de l’Opéra na has a 0% trademark registration rate, with 0 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.